Skip to main content Accessibility help

Monoamine Oxidase in Chronic Schizophrenia: Studies of Hormonal and other Factors affecting Enzyme Activity

  • Dennis L. Murphy (a1), Robert Belmaker (a2), William T. Carpenter (a3) and Richard J. Wyatt (a4)


Reported reductions in the activity of platelet monoamine oxidase (MAO) in chronic schizophrenic patients might be contributed to by alterations in hormones, platelet numbers or other non-specific factors thought to affect enzyme activity. In this study, MAO activity in 27 patients with chronic schizophrenia was measured, using benzylamine as the substrate in an assay based on platelet counts instead of platelet protein, and was found to be markedly lower than mean MAO activity in 375 normal controls. These results were similar to those previously reported with tryptamine as a substrate for the enzyme. Serum testosterone, triiodothyronine, iron and iron-binding capacity were within normal ranges in individuals with reduced MAO activity, and none of these measurements was significantly correlated with MAO activities. Platelet MAO activity remained stable over time in patients and controls.



Hide All
Belmaker, R., Murphy, D. L., Wyatt, R.J. & Loriaux, L. (1974) Human platelet monoamine oxidase changes during the menstrual cycle. Archives of General Psychiatry, 31, 553–6.
Brambilla, F. & Penati, G. (1970) Hormones and behavior in Schizophrenia. In Influence of Hormones on the Nervous System, Proc. Int. Soc. Psychoneuroendocrinology, pp 482–94, Brooklyn.
Carpenter, W. T., Murphy, D. L. & Wyatt, R. J. (1975) Platelet monoamine oxidase activity in acute schizophrenia. American Journal of Psychiatry, 132, 438–41.
Chopra, I. J., Ho, R. S. & Lam, R. (1972) An improved radioimmunoassay of triidothyronine in serum: its application to clinical and physiological studies. Journal of Laboratory and Clinical Medicine, 80, 729–39.
Cookson, I. B., Owen, F. & Ridges, A. P. (1975) Platelet monoamine oxidase activity during the course of a schizophreniform psychosis. Psychological Medicine, 314–16.
Domino, E. F. & Khanna, S. S. (1976) Decreased blood platelet MAO activity in unmediated chronic schizophrenic patients. American Journal of Psychiatry, 133, 323–6.
DSM-II (1968) Diagnostic and Statistical Manual of Mental Disorders, Second Edition. Washington: American Psychiatric Association.
Friedman, E. Shopsin, B., Sathananthan, G. & Gershon, S. (1974) Blood platelet MAO activity in psychiatric patients. American Journal of Psychiatry, 131, 1392–4.
Gaziri, L. C. J. & Ladosky, W. (1973) Monoamine oxidase variation during sexual differentiation. Neuroendocrinology, 12, 249–56.
Gentil, V., Greenwood, M. H. & Lader, M. H. (1975) The effect of adrenaline on human platelet MAO. Psychopharmocologia, 44, 187–94.
Goridis, C. & Neff, N. H. (1973) Neuronal and hormonal influences on the turnover of monoamine oxidase in salivary gland. Biochemical Pharmacology, 22, 2501–10.
Ho-Van-Hap, A., Babineau, L. M. & Berlinguet, L. (1967) Hormonal action on monoamine oxidase activity in rats. Canadian Journal of Biochemistry, 45, 355–62.
Levine, R. J., Oates, J. A., Vendsalu, A. & Sjoerdsma, A. (1962) Studies of the metabolism of aromatic amines in relation to altered thyroid function in man. Journal of Clinical Endocrinology and Metabolism, 22, 1242–50.
Lyles, G. A. & Callingham, B. A. (1974) The effects of thyroid hormones on monoamine oxidase in the rat heart. Journal of Pharmacy and Pharmacology, 26, 921–30.
Meltzer, H. Y. & Stahl, S. M. (1974) Platelet monoamine oxidase activity and substrate preferences in schizophrenia patients. Research Communications in Chemical Pathology and Pharmacology, 7, 419–31.
Miller, G. L. (1959) Protein determinations for large numbers of samples. Analytic Chemistry, 31, 964.
Murphy, D. L., Belmaker, R. & Wyatt, R. J. (1974) Monoamine oxidase in schizophrenia and other behavioral disorders. Journal of Psychiatric Research, 11, 221–48.
Murphy, D. L. & Wyatt, R. J. (1972) Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Nature, 238, 225–6.
Murphy, D. L. & Wyatt, R. J. (1975) Enzyme studies in the major psychiatric disorders: I. Catechol-O-methyl-transferase, monoamine oxidase in the affective disorders, and factors affecting some behavior-related enzyme activities. In The Biology of the Major Psychoses: A Comparative Analysis (ed Freedman, D. S.), pp 277–88. New York: Raven Press.
Murphy, D. L., Wright, C., Buchsbaum, M., Nichols, A., Costa, J. L. & Wyatt, R. J. (in press) Platelet and plasma amine oxidase activity in 680 normals: sex and age differences and stability over time. Biochem. med.
Nies, A., Robinson, D. S., Harris, L. S. & Lamborn, K. R. (1974) Comparison of monoamine oxidase substrate activities in twins, schizophrenics, depressives, and controls. In Neuropsychopharmacology of Monoamines and Their Regulatory Enzymes (ed. Usdin, E.), pp 5970. New York: Raven Press.
Redmond, D. E., Baulu, J., Murphy, D. L., Loriaux, D. L., Ziegler, M. G. & Lake, C. R. (in press) Effects of testosterone on plasma and platelet monoamine oxidase and plasma dopamine β-hydroxylase activities in the male rhesus monkey. Psychosomatic Medicine.
Redmond, D. E., Murphy, D. L., Ziegler, M. G., Lake, C. R. & Baulu, J. (1975) Menstrual cycle and ovarian hormone effects on plasma and platelet monoamine oxidase (MAO) and plasma dopamine beta-hydroxy-lase (DBH) activities in the rhesus monkey. Psychosomatic Medicine, 37, 417–28.
Robinson, D. S., Davis, J. M., Nies, A., Ravaris, C. L. & Sylwester, D. (1971) Relation of sex and aging to monoamine oxidase activity of human brain, plasma, and platelets. Archives of General Psychiatry, 24, 536–9.
Shaskan, E. G. & Becker, R. E. (1975) Platelet monoamine oxidase in schizophrenics. Nature, 253, 659–60.
Thorneycroft, I. H. & Stone, S. C. (1972) Radioimmunoassay of serum progesterone in women receiving oral contraceptive steroids. Contraception, 5, 129–46.
Wurtman, R. J. & Axelrod, J. (1963) Sex steroids, cardiac 3H-norepinephrine, and tissue monoamine oxidase levels in the rat. Biochemical Pharmacology, 12, 1417–19.
Wyatt, R. J., Murphy, D. L., Belmaker, R., Cohen, S., Donnelly, C. H. & Pollin, W. (1973) Reduced monoamine oxidase activity in platelets: A possible genetic marker for vulnerability to schizophrenia. Science, 179, 916–18.
Yee, H. Y. & Zin, A. (1971) An autoanalyzer procedure for serum iron and total iron-binding capacity, with use of ferrozine. Clinical Chemistry, 17, 950–3.
Youdim, M. B. H., Woods, H. F., Mitchell, B., Grahame-Smith, D. G. & Callender, S. (1975) Human platelet monoamine oxidase activity in iron-deficiency anaemia. Clinical Science and Molecular Medicine, 48, 280–95.
Zeller, E. A., Boshes, B., Davis, J. M. & Thorner, M. (1975) Molecular aberration in platelet monoamine oxidase in schizophrenia. Lancet, i, 1385.

Monoamine Oxidase in Chronic Schizophrenia: Studies of Hormonal and other Factors affecting Enzyme Activity

  • Dennis L. Murphy (a1), Robert Belmaker (a2), William T. Carpenter (a3) and Richard J. Wyatt (a4)


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

Monoamine Oxidase in Chronic Schizophrenia: Studies of Hormonal and other Factors affecting Enzyme Activity

  • Dennis L. Murphy (a1), Robert Belmaker (a2), William T. Carpenter (a3) and Richard J. Wyatt (a4)
Submit a response


No eLetters have been published for this article.


Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *